1. Flow cytometric analysis of leukemia cells and detection of minimal residual disease.
2. Monitoring of DNA aneuploidy and tumor marker expression in cells from body cavity fluids.
3. Use practice guidelines from ICCS to establish the validation process of cell-based fluorescence assays in the medical laboratory.